• Post treatment weight (kg)
• Post treatment apnea-hypopnea index (AHI)

• Change in snoring (Visual analogue scale) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Quality of life (FOSQ) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Excessive daytime sleepiness (ESS) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Waist-hip ratio (WHR) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Blood pressure [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Lipid and glucose levels [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Sleep fragmentation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Oxygen saturation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
• Post treatment AHI [ Time Frame: 6 months ] [ Designated as safety issue: No ]

• Change in snoring (Visual analogue scale)
• Quality of life
• Excessive daytime sleepiness
• Body mass index (BMI)
• Waist-hip ratio (WHR)
• Blood pressure
• Neck size
• Lipid and glucose levels
• Sleep fragmentation
• Oxygen saturation

The purpose of the study is to determine if weight loss interventions aimed at lifestyle modification (dietary education, food diary pedometer) result in weight loss in patients with mild-moderate obstructive sleep apnea (OSA) when compared to usual patient care. The secondary purpose of the study is to determine if the amount of weight loss achieved in a 6 month period results in improvements in snoring and other symptoms and in the frequency of apnea on overnight monitoring.

The purpose of the study is to determine if weight loss interventions aimed at lifestyle modification (dietary education, food diary pedometer) result in weight loss in patients with mild-moderate obstructive sleep apnea (OSA) when compared to usual patient care. The secondary purpose of the study is to determine if the amount of weight loss achieved in a 6 month period results in improvements in snoring and other symptoms and in the frequency of apnea on overnight monitoring.

Primary Objective

• To determine if weight loss interventions aimed at lifestyle modification (dietary education, food diary pedometer) result in weight loss in patients with mild-moderate OSA when compared to usual care.
• To determine if the amount of weight loss achieved in a 6 month period result in improvements in objective measures of sleep disordered breathing (AHI).

Secondary Objective

• To determine if the weight loss achieved in 6 months result in improvements in OSA symptoms (e.g., snoring, sleepiness) and quality of life.
• To determine if metabolic parameters (e.g., lipids, glucose) improve.
• To determine if there is improvement in sleep structure and oxygenation during sleep.

• No Intervention: Usual Clinical Care
• Experimental: Behavioral (e.g., Counseling)

Inclusion Criteria:

• Patients who have undergone a sleep study at the London Health Sciences Centre or St. Thomas Elgin General Hospital Sleep Laboratory and who are newly diagnosed with obstructive sleep apnea
• Patients with an age over 18 years
• Patients who have an apnea-hypopnea index (AHI) of 5-40 per hour (mild-to-moderate OSA)
• Patients who have an elevated body mass index (BMI) of 28 to 39 kg/m2
• Patients who have an Epworth Sleepiness Scale score ≤11

Exclusion Criteria:

Patients will not be recruited:

• if they are on weight loss medications
• if they have seen a registered dietician in the preceding 6 months for dietary counseling
• if they have attended a weight loss program in the last 6 months
• if they have a history of a car accident related to sleepiness or report sleepiness when driving
• if they work in a safety critical occupation and require treatment for work reasons
• if they have serious or unstable cardiac co-morbidity
• if they are unable or unwilling to provide informed consent
• if they are pregnant
• if they are unwilling to return for follow-up visits